Menopausal Hormone Therapy Safety: What the 2026 Reappraisal Says
A 2026 review reappraises menopausal hormone therapy safety: the benign window before 60 or within 10 years, and what favorable benefit-risk does not mean.
Category Longevity Research
Selank Research: Tuftsin Analog Evidence and Limits
Selank research overview for women 40+: tuftsin-analog structure, GABA-A and BDNF study findings, the small human-trial record, and what remains unproven.
MHT and Alzheimer’s Research: What the 2026 Study Found
A 2026 Neurology cohort study linked estrogen-only menopausal hormone therapy with lower odds of Alzheimer pathology. Review the findings and limits.
Glutathione and Oxidative Stress Research for Women Over 40
Review glutathione and oxidative stress research in aging, menopause, redox biology, skin studies, evidence limits, and questions for women over 40.